Heyoka955/rteee huggingface dataset:
04 aug 25   blackrock greater europe investment trust plc - total voting rights blackrock greater europe investment trust plc | brge | 573 0 0.0% | mkt cap: 547.3m    blackrock greater europe investment trust plc (the “company”) lei - 5493003r8fj6i76zuw55   voting rights and capital (article 15 transparency directive, dtr 5.6)   in conformity with the fca's disclosure guidance and transparency rules ("the rules") provision 5.6.1, the company would like to notify the market that as at 04 august 2025 its issued capital comprised 95,518,569 ordinary shares of £0.01 each, excluding 22,410,369 shares held in treasury.   shareholders should therefore use 95,518,569 (being the company’s issued share capital excluding shares held in treasury) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the company under the rules.     all enquiries:   caroline driscoll company secretary blackrock investment management (uk) limited tel: 0207 743 2427   04 august 2025   release return to news summary

Label: Neutral
04 aug 25   primary health props - director/pdmr shareholdings primary health properties plc | php | 96.1 0 0.0% | mkt cap: 1,285m    rns number : 7286t primary health properties plc 04 august 2025   primary health properties plc ("php" or the "company"),     director/pdmr shareholdings     the company has been notified that the following information relating to the transaction detailed below has been filed with the fca in accordance with article 19(1) of the market abuse regulation. 1 details of person discharging managerial responsibilities/person closely associated (a) name harry hyman   2 reason for notification (a) position/status non-executive chair (b) initial notification/amendment initial notification   3 details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor   (a) name   primary health properties plc (b) lei 213800y5cjhxoatk7x11   4 details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted (a) description of the financial instrument ordinary shares of 12.5p isin: gb00byrj5j14 (b) nature of the transaction purchase   (c) price(s) and volume(s) price(s) volume(s) £0. 958 25,660 (d) aggregated volume price single transaction £24,579.82   (e) date of transaction 1 august 2025   (f) place of transaction london stock exchange (xlon)     for further information primary health properties plc   toby newman, company secretary & chief legal officer +44(0) 7729 047 959   legal entity identifier: 213800y5cjhxoatk7x11 this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   dshmzggrrzmgkzg return to news summary

Label: Gesunken
04 aug 25   anglo-eastern plant. - appointment of financial adviser and broker anglo-eastern plantations plc | aep | 893 0 0.0% | mkt cap: 351.8m    rns number : 7185t anglo-eastern plantations plc 04 august 2025   anglo-eastern plantations plc ("aep", "group" or the "company")   appointment of financial adviser and broker   anglo-eastern plantations plc, which owns, operates and develops plantations in indonesia and malaysia, is pleased to announce the appointment of cavendish capital markets limited as financial adviser and broker with immediate effect. for further enquiry, contact: anglo-eastern plantations plc +44 (0) 20 7216 4621 marcus chan jau chwen, executive director (corporate affairs)   kevin wong tack wee, group chief executive officer       cavendish capital markets limited - financial adviser and broker +44 (0) 20 7220 0500 matt goode, george lawson, trisyia jamaludin (corporate finance)   tim redfern, harriet ward (corporate broking)           this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   appssffmfeiseia return to news summary

Label: Neutral
04 aug 25   primary health props - director/pdmr shareholdings primary health properties plc | php | 96.1 0 0.0% | mkt cap: 1,285m    rns number : 7284t primary health properties plc 04 august 2025   primary health properties plc ("php" or the "company"),     director/pdmr shareholdings     the company has been notified that the following information relating to the transaction detailed below has been filed with the fca in accordance with article 19(1) of the market abuse regulation. 1 details of person discharging managerial responsibilities/person closely associated (a) name mark davies   2 reason for notification (a) position/status chief executive officer (b) initial notification/amendment initial notification   3 details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor   (a) name   primary health properties plc (b) lei 213800y5cjhxoatk7x11   4 details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted (a) description of the financial instrument ordinary shares of 12.5p isin: gb00byrj5j14 (b) nature of the transaction purchase   (c) price(s) and volume(s) price(s) volume(s) £0.96 38,261 (d) aggregated volume price single transaction £36,734.39   (e) date of transaction 1 august 2025   (f) place of transaction london stock exchange (xlon)     for further information primary health properties plc   toby newman, company secretary & chief legal officer +44(0) 7729 047 959   legal entity identifier: 213800y5cjhxoatk7x11 this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   dshgzggrrzrgkzg return to news summary

Label: Gesunken
05 aug 25   caledonia mining crp - notice of results caledonia mining corporation plc | cmcl | 1,535 0 0.0% | mkt cap: 296.2m    rns number : 9175t caledonia mining corporation plc 05 august 2025   caledonia mining corporation plc notice of q2 2025 results and investor presentation (nyse american, aim and vfex: cmcl) st helier, august 5,  2025 - caledonia mining corporation plc ("caledonia" or "the company") expects to publish its operating and financial results for the quarter ended june 30, 2025 on monday august 11, 2025. due to there being a public holiday in zimbabwe on august 11 and 12, a remote presentation for analysts and investors will be held on wednesday august 13, 2025 at 2:00pm london time, followed by an opportunity for q&a. a presentation of the results and outlook for caledonia will be available on caledonia's website (www.caledoniamining.com). conference call details   a presentation for investors and analysts will be held as follows:   when: august 13, 2025 at 2:00pm london time topic: q2 2025 results call for investors register in advance for this webinar: https://brrmedia.news/cmcl_q225   enquiries: caledonia mining corporation plc mark learmonth camilla horsfall   tel: +44 1534 679 800 tel: +44 7817 841 793 cavendish capital markets limited (nomad and joint broker) adrian hadden george lawson   tel: +44 207 397 1965   panmure liberum limited (joint broker) scott mathieson   tel: +44 20 3100 2000 camarco, financial pr (uk) gordon poole elfie kent   tel: +44 20 3757 4980 3ppb (financial pr, north america) patrick chidley paul durham   tel: +1 917 991 7701 tel: +1 203 940 2538 curate public relations (zimbabwe) debra tatenda   tel: +263 77802131 ih securities (private) limited (vfex sponsor - zimbabwe) lloyd mlotshwa       tel: +263 (242) 745 119/33/39     this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   norfzggrvdlgkzm return to news summary

Label: Neutral
05 aug 25   union jack oil plc - notice of general meeting union jack oil plc | ujo | 5.0 0 0.0% | mkt cap: 7.26m    rns number : 9011t union jack oil plc 05 august 2025     5 august 2025   union jack oil plc ("union jack" or the "company") notice of general meeting union jack oil plc (aim: ujo), a uk and usa focused onshore hydrocarbon production, development and exploration company announces that, further to the fundraising announced on 23 july 2025, a notice of general meeting (the "general meeting") will be posted to shareholders today and will be available shortly on the company's website: www.unionjackoil.com the general meeting will be held on 26 august 2025 at 11:00 a.m. at the george white suite, the bristol hotel, prince street, bristol bs1 4qf. at the general meeting a resolution will be proposed to authorise the directors to issue the warrants relating to the fundraising and to empower them to disapply pre-emption rights in relation to the allotment of ordinary shares for cash pursuant to the exercise of the warrants.     for further information, please contact:   union jack oil plc                                                                                       info@unionjackoil.com david bramhill, executive chairman   sp angel corporate finance llp                                                             +44 (0)20 3470 0470 nominated adviser and joint broker matthew johnson richard hail jen clarke   zeus capital limited                                                                                  +44 (0)20 3829 5000 joint broker antonio bossi simon johnson george duxberry this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   nogssdfileisefa return to news summary

Label: Neutral
05 aug 25   big yellow group plc - development update big yellow group plc | byg | 933 0 0.0% | mkt cap: 1,836m    rns number : 9020t big yellow group plc 05 august 2025     5 august 2025   big yellow group plc ("big yellow", "the group" or "the company")   development update   big yellow is pleased to announce that it has opened its new 70,000 sq ft store at staines, west london.  the store is located prominently on the causeway and will serve a new catchment area for big yellow, with our nearest store seven miles away.  we have a further three stores due to open this financial year; queensbury, london (72,000 sq ft opening in october 2025), slough bath road (95,000 sq ft opening in february 2026), and wembley, london (73,000 sq ft opening in march 2026).  we anticipate opening a further four stores in the year ending 31 march 2027, with west kensington, london following in 2028.   jim gibson, ceo, commented: "this is the first opening of the nine sites that we are currently constructing, which will add 730,000 sq ft of capacity (11% of our current mla).  these sites, along with the other five in our pipeline, will add a proforma net operating income of approximately £37 million, a return of 8.8% on the total development cost of £422 million, including land already acquired, of which £214 million has been spent to date."   enquiries:   nicholas vetch cbe, executive chairman                                        01276 477811 jim gibson, chief executive officer                                                 01276 477811 john trotman, chief financial officer                                               01276 477811   sodali  & co                                                                                       0207 100 6451 ben foster this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   updupugprupagac return to news summary

Label: Neutral
05 aug 25   primary health props - director/pdmr shareholding primary health properties plc | php | 96.1 0 0.0% | mkt cap: 1,285m    rns number : 9258t primary health properties plc 05 august 2025   primary health properties plc ("php" or the "company"),     director/pdmr shareholdings     the company has been notified that the following information relating to the transaction detailed below has been filed with the fca in accordance with article 19(1) of the market abuse regulation. 1 details of person discharging managerial responsibilities/person closely associated (a) name mark davies   2 reason for notification (a) position/status chief executive officer (b) initial notification/amendment initial notification   3 details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor   (a) name   primary health properties plc (b) lei 213800y5cjhxoatk7x11   4 details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted (a) description of the financial instrument ordinary shares of 12.5p isin: gb00byrj5j14 (b) nature of the transaction purchase   (c) price(s) and volume(s) price(s) volume(s) £0.959 77,820 (d) aggregated volume price single transaction £74,629.38   (e) date of transaction 4 august 2025   (f) place of transaction london stock exchange (xlon)     for further information primary health properties plc   toby newman, company secretary & chief legal officer +44(0) 7729 047 959   legal entity identifier: 213800y5cjhxoatk7x11 this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   dshbigdibsgdgus return to news summary

Label: Gesunken
05 aug 25   tungsten west plc - completion of updated feasibility study tungsten west plc | tun | 8.2 0 0.0% | mkt cap: 15.6m    rns number : 9187t tungsten west plc 05 august 2025   05 august 2025 tungsten west plc ("tungsten west", the "company" or the "group")   completion of updated feasibility study   tungsten west (lon:tun), the mining company focused on restarting production at the hemerdon tungsten and tin mine ("hemerdon" or the "project") in devon, uk, is pleased to announce the completion of its updated feasibility study (the "study") for hemerdon. an executive summary of the feasibility study is available on the company's website via the following link: www.tungstenwest.com/technicalreports   the company announced on 30 may 2025 a preview of the project's economics. these remain unchanged with an irr of 29% and an npv7.5% of us$190 million using a tungsten price of us$400 per metric tonne unit (65% ammonium paratungstate, ("apt"), free on-board rotterdam).   the company will be hosting a live investor presentation in september, further details will follow in due course.   jeff court, ceo of tungsten west, commented: "the conclusion of this feasibility study marks a highly significant milestone for tungsten west as we now formally commence our fundraising efforts. the study further emphasises the strong economics of the project, fully supported by its strong technical, environmental, community and stakeholder facets. the study also further underlines hemerdon's global critical minerals supply credentials.   "i would like to sincerely thank the entire team, including our employees and consultants for their extremely hard work to complete this study. in addition, i would also like to thank our shareholders and financial supporters for their continued dedication and belief in our project."   ends   for further information, please contact:   enquiries tungsten west alistair stobie tel: +44 (0) 1752 278500   strand hanson (nominated adviser and financial adviser) james spinney / james dance / abigail wennington tel: +44 (0) 207 409 3494 blytheray (financial pr) tim blythe / megan ray tel: +44(0) 20 7138 3204 email:  tungstenwest@blytheray.com   hannam & partners (broker) andrew chubb / matt hasson / jay ashfield tel: +44 (0)20 7907 8500    follow us on x @tungstenwest   this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   mscblgdicsgdgus return to news summary

Label: Gestiegen
05 aug 25   blackrock smaller companies trust plc - total voting rights blackrock smaller companies trust plc | brsc | 0 0 0.0% | mkt cap: 606.8m    blackrock smaller companies trust plc (the “company”) lei - 549300ms535kc2wh4082   voting rights and capital (article 15 transparency directive, dtr 5.6)   in conformity with the fca's disclosure guidance and transparency rules ("the rules") provision 5.6.1, the company would like to notify the market that as at 05 august 2025 its issued capital comprised 42,162,792 ordinary shares of £0.25 each, excluding 7,830,731 shares held in treasury.   shareholders should therefore use 42,162,792 (being the company’s issued share capital excluding shares held in treasury) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the company under the rules.     all enquiries:   graham venables company secretary blackrock investment management (uk) limited tel: 0203   649   3432   05 august 2025  return to news summary

Label: Neutral
05 aug 25   blackrock american income trust plc - total voting rights blackrock american income trust plc gbp | brai | 200 -1.0 (-0.5%) | mkt cap: 112.6m    blackrock american income trust plc (the “company”) lei - 549300wwocxsc241w468   voting rights and capital (article 15 transparency directive, dtr 5.6)   in conformity with the fca's disclosure guidance and transparency rules ("the rules") provision 5.6.1, the company would like to notify the market that as at 05 august 2025 its issued capital comprised 56,412,138 ordinary shares of £0.01 each, excluding 38,949,167 shares held in treasury.   shareholders should therefore use 56,412,138 (being the company’s issued share capital excluding shares held in treasury) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the company under the rules.     all enquiries:   kevin mayger company secretary blackrock investment management (uk) limited tel: 0207 743 1098   05 august 2025   release return to news summary

Label: Gesunken